Yahui Ding

2.7k total citations · 1 hit paper
87 papers, 1.8k citations indexed

About

Yahui Ding is a scholar working on Molecular Biology, Cancer Research and Organic Chemistry. According to data from OpenAlex, Yahui Ding has authored 87 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 26 papers in Cancer Research and 22 papers in Organic Chemistry. Recurrent topics in Yahui Ding's work include Sesquiterpenes and Asteraceae Studies (16 papers), Synthetic Organic Chemistry Methods (13 papers) and Ubiquitin and proteasome pathways (11 papers). Yahui Ding is often cited by papers focused on Sesquiterpenes and Asteraceae Studies (16 papers), Synthetic Organic Chemistry Methods (13 papers) and Ubiquitin and proteasome pathways (11 papers). Yahui Ding collaborates with scholars based in China, United States and Japan. Yahui Ding's co-authors include Yue Chen, Quan Zhang, Weizhi Ge, Xin Hao, Hai Zou, Mengmeng Wang, Can Liu, Qin Wang, Xiaoping Chen and Jing Long and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and Chemical Communications.

In The Last Decade

Yahui Ding

82 papers receiving 1.7k citations

Hit Papers

Identification of a small molecule as inducer of ferropto... 2021 2026 2022 2024 2021 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yahui Ding China 23 976 506 295 280 247 87 1.8k
Quan Zhang China 28 1.3k 1.3× 623 1.2× 414 1.4× 528 1.9× 390 1.6× 83 2.3k
Donghwa Kim South Korea 19 764 0.8× 192 0.4× 219 0.7× 140 0.5× 313 1.3× 42 1.3k
Bhaumik B. Patel United States 25 1.3k 1.3× 469 0.9× 230 0.8× 155 0.6× 805 3.3× 62 2.3k
Vincent C. Daniel United States 14 1.3k 1.3× 314 0.6× 501 1.7× 191 0.7× 631 2.6× 23 2.8k
Ying Sun China 24 1.1k 1.1× 392 0.8× 207 0.7× 222 0.8× 379 1.5× 93 2.1k
Gi‐Ming Lai Taiwan 28 1.3k 1.4× 493 1.0× 213 0.7× 166 0.6× 828 3.4× 57 2.5k
Ming‐Shyue Lee Taiwan 28 1.2k 1.3× 427 0.8× 435 1.5× 75 0.3× 405 1.6× 52 2.2k
Changzheng Li China 22 719 0.7× 277 0.5× 205 0.7× 123 0.4× 240 1.0× 78 1.4k
Jiřina Hofmanová Czechia 24 859 0.9× 338 0.7× 182 0.6× 116 0.4× 314 1.3× 82 1.5k
Amro Aboukameel United States 31 2.0k 2.0× 611 1.2× 166 0.6× 123 0.4× 1.0k 4.2× 91 2.8k

Countries citing papers authored by Yahui Ding

Since Specialization
Citations

This map shows the geographic impact of Yahui Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yahui Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yahui Ding more than expected).

Fields of papers citing papers by Yahui Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yahui Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yahui Ding. The network helps show where Yahui Ding may publish in the future.

Co-authorship network of co-authors of Yahui Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Yahui Ding. A scholar is included among the top collaborators of Yahui Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yahui Ding. Yahui Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mei, Wentong, Yahui Ding, Chunjing Bian, et al.. (2025). The aryl hydrocarbon receptor inhibits antigen presentation to promote progression of pancreatic ductal adenocarcinoma. Journal of Advanced Research.
3.
Du, Honglin, Yongping Bai, Yahui Ding, et al.. (2025). A general leaving group assisted strategy for synthesis of pentafluorosulfanyl allylic compounds. PubMed Central. 11(30). eadw8408–eadw8408. 3 indexed citations
4.
Liu, Can, Mengmeng Wang, Yan Jiao, et al.. (2025). BE-43547A2 exerts hypoxia-selective inhibition on human pancreatic cancer cells through targeting eEF1A1 and disrupting its association with FoxO1. Acta Pharmacologica Sinica. 46(5). 1433–1444. 1 indexed citations
6.
Wang, Qin, Can Liu, Fengyuan Zhang, et al.. (2024). Ovatodiolide inhibited hepatocellular carcinoma stemness through SP1/MTDH/STAT3 signaling pathway. Chemico-Biological Interactions. 400. 111161–111161.
7.
Zhang, Fengyuan, et al.. (2024). Natural product mediated mesenchymal–epithelial remodeling by covalently binding ENO1 to degrade m6A modified β-catenin mRNA. Acta Pharmaceutica Sinica B. 15(1). 467–483. 1 indexed citations
8.
Wang, Tianpeng, Tianyang Chen, Qıang Zhang, et al.. (2023). Cytotoxic Terpenes from the Flowers of Inula japonica against Human Hepatocarcinoma Cells. Chemistry & Biodiversity. 20(5). e202300220–e202300220. 1 indexed citations
9.
Guo, Jianshuang, Juanjuan Li, Yang Liu, et al.. (2023). Dual hypoxia-responsive supramolecular complex for cancer target therapy. Nature Communications. 14(1). 5634–5634. 27 indexed citations
10.
Zhang, Haifei, et al.. (2020). Tislelizumab for the treatment of classical Hodgkin's lymphoma. Drugs of today. 56(12). 781–781. 7 indexed citations
11.
Sun, Yu, Bowen Liu, Jiabo Li, et al.. (2020). ACT001 modulates the NF-κB/MnSOD/ROS axis by targeting IKKβ to inhibit glioblastoma cell growth. Journal of Molecular Medicine. 98(2). 263–277. 37 indexed citations
12.
Li, Yinghui, Mei He, Ming Yang, et al.. (2020). Antioxidant Small Molecule Compound Chrysin Promotes the Self-Renewal of Hematopoietic Stem Cells. Frontiers in Pharmacology. 11. 399–399. 13 indexed citations
13.
Ge, Weizhi, Xin Hao, Zhong‐Quan Liu, et al.. (2019). Synthesis and structure-activity relationship studies of parthenolide derivatives as potential anti-triple negative breast cancer agents. European Journal of Medicinal Chemistry. 166. 445–469. 34 indexed citations
14.
Ding, Yahui, Hongyu Guo, Weizhi Ge, et al.. (2018). Copper(I) oxide nanoparticles catalyzed click chemistry based synthesis of melampomagnolide B-triazole conjugates and their anti-cancer activities. European Journal of Medicinal Chemistry. 156. 216–229. 31 indexed citations
15.
Chen, Jian, Jingpei Li, Lingling Wu, et al.. (2018). Syntheses and anti-pancreatic cancer activities of rakicidin A analogues. European Journal of Medicinal Chemistry. 151. 601–627. 14 indexed citations
16.
Zou, Hai, et al.. (2017). Trimetazidine in conditions other than coronary disease, old drug, new tricks?. International Journal of Cardiology. 234. 1–6. 13 indexed citations
17.
Li, Yongtao, Jinghan Wang, Xiaoqian Chu, et al.. (2016). Syntheses and biological evaluation of 1,2,3-triazole and 1,3,4-oxadiazole derivatives of imatinib. Bioorganic & Medicinal Chemistry Letters. 26(5). 1419–1427. 33 indexed citations
18.
Yang, Zhongjin, Kang Ning, Yahui Ding, et al.. (2016). Synthesis and anti-acute myeloid leukemia activity of C-14 modified parthenolide derivatives. European Journal of Medicinal Chemistry. 127. 296–304. 18 indexed citations
19.
Ding, Yahui, Hongxia Fan, Jing Long, Quan Zhang, & Yue Chen. (2013). The application of Heck reaction in the synthesis of guaianolide sesquiterpene lactones derivatives selectively inhibiting resistant acute leukemic cells. Bioorganic & Medicinal Chemistry Letters. 23(22). 6087–6092. 35 indexed citations
20.
Yuan, Xiangfei, Hongwei Peng, Yahui Ding, et al.. (2012). Gene therapy in B-NHL cell line using adenovirus-mediated transfer of secretable trimeric TRAIL gene expression driven by CD20 promoter. Experimental Hematology. 41(3). 221–230. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026